Their approach promises a permanent cure and potential for protection against HIV
The HIV-1 virus has proved to be tenacious, inserting its genome permanently into its victims’ DNA, forcing patients to take a lifelong drug regimen to control the virus and prevent a fresh attack. Now, a team of Temple University School of Medicine researchers has designed a way to snip out the integrated HIV-1 genes for good.
“This is one important step on the path toward a permanent cure for AIDS,” says Kamel Khalili, PhD, Professor and Chair of the Department of Neuroscience at Temple. Khalili and his colleague, Wenhui Hu, MD, PhD, Associate Professor of Neuroscience at Temple, led the work which marks the first successful attempt to eliminate latent HIV-1 virus from human cells. “It’s an exciting discovery, but it’s not yet ready to go into the clinic. It’s a proof of concept that we’re moving in the right direction,” added Dr. Khalili, who is also Director of the Center for Neurovirology and Director of the Comprehensive NeuroAIDS Center at Temple.
In a study published July 21 by the Proceedings of the National Academy of Sciences, Khalili and colleagues detail how they created molecular tools to delete the HIV-1 proviral DNA. When deployed, a combination of a DNA-snipping enzyme called a nuclease and a targeting strand of RNA called a guide RNA (gRNA) hunt down the viral genome and excise the HIV-1 DNA. From there, the cell’s gene repair machinery takes over, soldering the loose ends of the genome back together – resulting in virus-free cells.
“Since HIV-1 is never cleared by the immune system, removal of the virus is required in order to cure the disease,” says Khalili, whose research focuses on the neuropathogenesis of viral infections. The same technique could theoretically be used against a variety of viruses, he says.
The research shows that these molecular tools also hold promise as a therapeutic vaccine; cells armed with the nuclease-RNA combination proved impervious to HIV infection.
Worldwide, more than 33 million people have HIV, including more than 1 million in the United States. Every year, another 50,000 Americans contract the virus, according to the U.S. Centers for Disease Control and Prevention.
Read more . . .
The Latest on: HIV
[google_news title=”” keyword=”HIV” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: HIV
- Why Tennessee is turning down millions of federal dollars for HIV preventionon February 3, 2023 at 8:27 am
State officials said they will instead use state funds they can control, including cutting out organizations tied to abortion care.
- AIDS Memorial Quilt Heads to New Orleans and Baton Rouge to Change the Pattern and End HIV in Black and Brown Communitieson February 3, 2023 at 4:29 am
Louisiana has the fourth highest HIV diagnoses rates in the country, so beginning on Feb. 7, National Black HIV/AIDS Awareness Day, sections of the ...
- African leaders commit to ending HIV in childrenon February 2, 2023 at 3:51 pm
Ministers and representatives from 12 African countries gathered for the first ministerial meeting of the Global Alliance to End AIDS in Children on Wednesday in Tanzania, and laid out action plans ...
- Gilead profit beats Street expectations on COVID and HIV saleson February 2, 2023 at 3:05 pm
Gilead Sciences Inc on Thursday reported a higher-than-expected fourth-quarter profit driven by strong demand for its HIV and cancer drugs, while COVID-19 antiviral Veklury had sales that were double ...
- Oncology, HIV sales lift Gilead’s revenues by 2%on February 2, 2023 at 1:44 pm
An increase in sales of oncology, HIV and hepatitis C drugs boosted Gilead Sciences’ quarterly revenues by 2%, according to the company’s most recent earnings report released Thursday evening. During ...
- How Tennessee axed millions in HIV funds amid scrutiny from far-right provocateurson February 2, 2023 at 11:33 am
Tennessee decided to scrap $8.3 million in federal grants to combat HIV after Matt Walsh and Ben Shapiro took aim at gender dysphoria treatment for minors.
- Funding Awarded for Study of HIV and Gum Diseaseon February 2, 2023 at 8:05 am
Tulane University researchers are studying whether dysregulation of the oral microbiome might affect HIV outcomes. They are using rhesus monkeys and SIV infection as a model.
- Can This Nation End HIV in Children?on February 1, 2023 at 5:20 pm
In the quest to end HIV among children by 2030, the southern African nation of Zimbabwe is making major progress. Tendayi Westerhof, the National Director of Pan African Positive Women’s Coalition of ...
- No regret over HIV legal action - rugby star's exon February 1, 2023 at 11:22 am
Gareth Thomas's former partner says the settlement has brought closure following his HIV diagnosis.
- ‘Prized’ professor stole HIV research funds to splurge on tropical vacations, feds sayon February 1, 2023 at 11:18 am
A university professor secretly used HIV research grants to bankroll his lavish lifestyle, which included numerous vacations, international flights and a birthday blowout at a tropical resort, ...
via Bing News